| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 10, 2019Virtual Press Office and PR Newswire: General Trade show news
Converging Supply Chain Markets and Accelerated SaaS Adoption Drive Record-Breaking Momentum MONTREAL, Dec. 10, 2019 /PRNewswire/ -- Tecsys Inc. (TSX: TCS), an industry-leading supply chain...
-
Dec 10, 2019Virtual Press Office and PR Newswire: General Trade show news
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the Phase 3 CANDOR study showing the addition of DARZALEX® (daratumumab) to carfilzomib (Kyprolis®) and...
-
Dec 10, 2019Virtual Press Office and PR Newswire: General Trade show news
Amgen (NASDAQ:AMGN) today announced additional results from the primary analysis of the Phase 3 CANDOR study evaluating KYPROLIS® (carfilzomib) in combination with dexamethasone and DARZALEX®...
-
Dec 10, 2019Virtual Press Office and PR Newswire: General Trade show news
Salesforce (NYSE: CRM), the global leader in CRM, today announced that Bill Patterson, EVP & GM, Service Cloud, will participate in an investor meeting hosted by Goldman Sachs & Co. on Tuesday,...
-
Dec 10, 2019Virtual Press Office and PR Newswire: General Trade show news
MYOS RENS Technology, Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk...
